2024 UBS Global Healthcare Conference on November 12 Stifel 2024 Healthcare Conference on November 18 Jefferies London Healthcare Conference on November 19 SAN DIEGO , Nov. 5, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) will participate at three upcoming investor conferences in November.
Chief Executive Officer Kyle Gano , Chief Financial Officer Matt Abernethy , and Vice-President of Investor Relations Todd Tushla will present at the 2024 UBS Global Healthcare Conference at 1:15 p.m. Pacific Time ( 4:15 p.
m. Eastern Time ) on Tuesday November 12, 2024 in Rancho Palos Verdes, CA. Chief Financial Officer Matt Abernethy and Chief Commercial Officer Eric Benevich will present at the Stifel 2024 Healthcare Conference at 10:55 a.
m. Eastern Time on Monday November 18, 2024 in New York . Chief Executive Officer Kyle Gano , Chief Financial Officer Matt Abernethy , and Chief Medical Officer Eiry Roberts will present at the Jefferies London Healthcare Conference at 1:30 p.
m. Greenwich Mean Time ( 8:30 a.m.
Eastern Time ) on Tuesday November 19, 2024 in London, United Kingdom . The live presentations will be webcast and may be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.
com . A replay of the webcasts will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month. About Neurocrine Biosciences Neurocrine Biosciences is a leading neuroscience-focused, biophar.
